|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-1-14
|
|
pubmed:abstractText |
The levonorgestrel intrauterine system (LNG-IUS) is a contraceptive device that is used for treatment of menorrhagia. The system induces inter-menstrual bleeding within the first few months after insertion. We hypothesized that this bleeding might be associated with a change in vascular development.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0268-1161
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
77-84
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:12525444-Actins,
pubmed-meshheading:12525444-Adult,
pubmed-meshheading:12525444-Antigens, CD31,
pubmed-meshheading:12525444-Arterioles,
pubmed-meshheading:12525444-Blood Vessels,
pubmed-meshheading:12525444-Endometrium,
pubmed-meshheading:12525444-Female,
pubmed-meshheading:12525444-Hormones,
pubmed-meshheading:12525444-Humans,
pubmed-meshheading:12525444-Immunohistochemistry,
pubmed-meshheading:12525444-Intrauterine Devices,
pubmed-meshheading:12525444-Levonorgestrel,
pubmed-meshheading:12525444-Muscle, Smooth,
pubmed-meshheading:12525444-Myosins,
pubmed-meshheading:12525444-Neovascularization, Physiologic
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Hormonally mediated disturbance of angiogenesis in the human endometrium after exposure to intrauterine levonorgestrel.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynaecology, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
